| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.29642 |
| P698 | PubMed publication ID | 26077342 |
| P50 | author | Ulrich Wellner | Q83171347 |
| Jochen Maurer | Q37374252 | ||
| Tilman Brummer | Q43375998 | ||
| P2093 | author name string | Marc P Stemmler | |
| Ulrich T Hopt | |||
| Thomas Brabletz | |||
| Vignesh Sundararajan | |||
| Simone Brabletz | |||
| Jessica Pfannstiel | |||
| Bogdan-Tiberius Preca | |||
| Kerstin Mock | |||
| Karolina Bajdak | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing | Q24321530 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| Phenotypic characterization of human colorectal cancer stem cells | Q24674126 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| CD44: from adhesion molecules to signalling regulators | Q28201701 | ||
| Cancer stem cells: mirage or reality? | Q28257690 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells | Q28294874 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 | ||
| The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs | Q29615910 | ||
| Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 | ||
| A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery | Q30443764 | ||
| Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing | Q33738028 | ||
| DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma | Q34171014 | ||
| miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions | Q34237504 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| Correlation of CD44v6 expression with ovarian cancer progression and recurrence | Q34658867 | ||
| CD44 is required for two consecutive steps in HGF/c-Met signaling. | Q35805198 | ||
| Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations | Q36941497 | ||
| Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer | Q37185159 | ||
| CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? | Q37851351 | ||
| Dormancy and breast cancer | Q37907088 | ||
| Regulatory networks defining EMT during cancer initiation and progression | Q38076317 | ||
| CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches | Q38100108 | ||
| A novel MCF-10A line allowing conditional oncogene expression in 3D culture | Q38267947 | ||
| Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma | Q38332106 | ||
| CD44 expression is associated with increased survival in node-negative invasive breast carcinoma | Q38442970 | ||
| Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development | Q39152992 | ||
| Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition | Q39282514 | ||
| TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. | Q39451094 | ||
| A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer | Q40235784 | ||
| Upregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells | Q40494890 | ||
| Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis | Q42439587 | ||
| Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression | Q45091351 | ||
| Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling | Q45749691 | ||
| Development and characterization of gemcitabine-resistant pancreatic tumor cells. | Q46971449 | ||
| Unravelling cancer stem cell potential. | Q53089167 | ||
| CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. | Q53241163 | ||
| CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray | Q57351327 | ||
| Stem Cells and Cancer: Two Faces of Eve | Q59243883 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2566-2577 | |
| P577 | publication date | 2015-06-30 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells | |
| P478 | volume | 137 |
| Q51176259 | 3-Phosphoinositide Dependent Protein Kinase-1 (PDK-1) Promotes Migration and Invasion in Gastric Cancer Cells Through Activating the NF-κB Pathway. |
| Q50964510 | 3D-spheroids: What can they tell us about pancreatic ductal adenocarcinoma cell phenotype? |
| Q37706944 | A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer |
| Q38720963 | A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. |
| Q26773907 | Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer |
| Q48053117 | CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy |
| Q64073580 | Co-expression of CD44/MyD88 is a poor prognostic factor in advanced epithelial ovarian cancer |
| Q38743845 | DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. |
| Q38616552 | Deciphering Epithelial-Mesenchymal Transition Regulatory Networks in Cancer through Computational Approaches |
| Q59615849 | Distinguishing mechanisms underlying EMT tristability |
| Q46518039 | Dual Roles for Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) in Cancer Progression |
| Q36860276 | Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets |
| Q98159128 | Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation |
| Q57021398 | Epigenetically Distinct Sister Chromatids and Asymmetric Generation of Tumor Initiating Cells |
| Q47260956 | Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview. |
| Q26770051 | Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation |
| Q64243517 | Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells |
| Q64996688 | Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential. |
| Q36409587 | Expression and Function of CD44 in Epithelial Ovarian Carcinoma |
| Q49192331 | Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers |
| Q92483800 | Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells |
| Q57980063 | Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer |
| Q48625336 | High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer |
| Q98384741 | Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis |
| Q89473587 | Inactivation of Zeb1 in GRHL2-deficient mouse embryos rescues mid-gestation viability and secondary palate closure |
| Q92648074 | Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas |
| Q91869765 | Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer |
| Q37189220 | Investigating the Molecular Basis of PPCD3: Characterization of ZEB1 Regulation of COL4A3 Expression |
| Q38697495 | LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells |
| Q37252859 | Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. |
| Q46236135 | MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. |
| Q37697134 | Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. |
| Q55364065 | Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells. |
| Q47148711 | Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells |
| Q93083337 | Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo |
| Q26764831 | New Insights into the Crossroads between EMT and Stemness in the Context of Cancer |
| Q64983562 | Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer. |
| Q89514370 | Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer |
| Q36282408 | Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression |
| Q26741215 | Pancreatic cancer stem cell markers and exosomes - the incentive push |
| Q90567920 | Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance |
| Q39039925 | Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer |
| Q38656079 | RNA-Binding Proteins in Cancer: Old Players and New Actors. |
| Q97546454 | RNA-binding proteins in tumor progression |
| Q47108793 | SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells. |
| Q38690536 | Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression |
| Q62788210 | Splicing factor controls ER-positive breast cancer by altering metabolic pathways |
| Q58757340 | Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2 |
| Q28079863 | Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors |
| Q28078716 | Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling |
| Q47123455 | The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells |
| Q41991370 | The ESRP1-GPR137 axis contributes to intestinal pathogenesis. |
| Q38925675 | The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer. |
| Q92932351 | The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing |
| Q33842650 | The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. |
| Q37673528 | The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer |
| Q38737174 | The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma |
| Q51703765 | The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis. |
| Q64123052 | Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition |
| Q37269126 | Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells |
| Q91714449 | ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance |
| Q55517228 | miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. |
Search more.